TrialJournal of translational medicine2014
Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis.
Alpha A Fowler et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
260 papers cite itlatest 60 shown
this paperpooled ittrialcites it